Benitec Biopharma Inc. (BNTC)
NASDAQ · Manufacturing · Pharmaceutical preparations
BNTC price, last 12 months
Key stats
- Previous close
- $8.27
- Open
- $8.34
- Day range
- $7.96 – $8.41
- 52-week range
- $7.72 – $14.39
- Volume
- 107.8K
- Avg volume (20 days)
- 180.4K
- Market cap
- $315.4M
Performance
Technicals and fundamentals
About Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $315.4M